Perrine Dahan

866 total citations
8 papers, 594 citations indexed

About

Perrine Dahan is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Perrine Dahan has authored 8 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Genetics and 3 papers in Oncology. Recurrent topics in Perrine Dahan's work include Glioma Diagnosis and Treatment (5 papers), Cancer Cells and Metastasis (3 papers) and Pluripotent Stem Cells Research (2 papers). Perrine Dahan is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Cancer Cells and Metastasis (3 papers) and Pluripotent Stem Cells Research (2 papers). Perrine Dahan collaborates with scholars based in France, United States and Russia. Perrine Dahan's co-authors include Anthony Lemarié, Christine Toulas, Michael A. Teitell, Vivian Lu, Sylvie Monferran, Julie Sesen, Laure Malric, Hu Li, Jin Zhang and Jing Zhao and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cell Metabolism.

In The Last Decade

Perrine Dahan

8 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perrine Dahan France 8 400 162 161 132 60 8 594
Yong-Kil Hong South Korea 15 234 0.6× 151 0.9× 255 1.6× 166 1.3× 46 0.8× 24 519
Yoshinari Shinsato Japan 14 284 0.7× 129 0.8× 75 0.5× 164 1.2× 52 0.9× 20 523
Kouichi Tabu Japan 14 332 0.8× 134 0.8× 124 0.8× 268 2.0× 69 1.1× 30 629
Siobhan Conroy Netherlands 9 215 0.5× 187 1.2× 165 1.0× 123 0.9× 44 0.7× 12 472
Nadine Abu-Kaoud Qatar 8 405 1.0× 214 1.3× 63 0.4× 209 1.6× 84 1.4× 9 663
Julie Sesen United States 8 250 0.6× 120 0.7× 94 0.6× 69 0.5× 30 0.5× 13 413
Hamda Al Thawadi Qatar 5 291 0.7× 141 0.9× 60 0.4× 92 0.7× 63 1.1× 6 464
Cecilia Krona Sweden 15 282 0.7× 158 1.0× 73 0.5× 96 0.7× 20 0.3× 21 486
Chen Zhu China 16 343 0.9× 208 1.3× 100 0.6× 180 1.4× 28 0.5× 35 680
Ying Jiang China 16 370 0.9× 185 1.1× 60 0.4× 152 1.2× 38 0.6× 52 675

Countries citing papers authored by Perrine Dahan

Since Specialization
Citations

This map shows the geographic impact of Perrine Dahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perrine Dahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perrine Dahan more than expected).

Fields of papers citing papers by Perrine Dahan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perrine Dahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perrine Dahan. The network helps show where Perrine Dahan may publish in the future.

Co-authorship network of co-authors of Perrine Dahan

This figure shows the co-authorship network connecting the top 25 collaborators of Perrine Dahan. A scholar is included among the top collaborators of Perrine Dahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perrine Dahan. Perrine Dahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lemarié, Anthony, V. Lubrano, Caroline Delmas, et al.. (2023). The STEMRI trial: Magnetic resonance spectroscopy imaging can define tumor areas enriched in glioblastoma stem-like cells. Science Advances. 9(44). eadi0114–eadi0114. 11 indexed citations
2.
Malric, Laure, Sylvie Monferran, Caroline Delmas, et al.. (2018). Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells. Molecular Cancer Research. 17(2). 384–397. 28 indexed citations
3.
Zhang, Jin, Jing Zhao, Perrine Dahan, et al.. (2018). Metabolism in Pluripotent Stem Cells and Early Mammalian Development. Cell Metabolism. 27(2). 332–338. 116 indexed citations
4.
Dahan, Perrine, et al.. (2018). Metabolism in pluripotency: Both driver and passenger?. Journal of Biological Chemistry. 294(14). 5420–5429. 59 indexed citations
5.
Delmas, Caroline, Anthony Lemarié, V. Lubrano, et al.. (2018). RND1 regulates migration of human glioblastoma stem-like cells according to their anatomical localization and defines a prognostic signature in glioblastoma. Oncotarget. 9(73). 33788–33803. 8 indexed citations
6.
Malric, Laure, Sylvie Monferran, Julia Gilhodes, et al.. (2017). Interest of integrins targeting in glioblastoma according to tumor heterogeneity and cancer stem cell paradigm: an update. Oncotarget. 8(49). 86947–86968. 79 indexed citations
7.
Sesen, Julie, Perrine Dahan, Sarah Scotland, et al.. (2015). Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response. PLoS ONE. 10(4). e0123721–e0123721. 170 indexed citations
8.
Dahan, Perrine, Caroline Delmas, Sylvie Monferran, et al.. (2014). Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance. Cell Death and Disease. 5(11). e1543–e1543. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026